Direct answer
An adjunct adds value when it addresses a specific problem, has evidence relevant to the patient and procedure, offers a meaningful benefit, and carries reasonable cost and risk. It may add cost without proven benefit when it is bundled routinely, described with vague biologic language, supported mainly by laboratory or surrogate outcomes, or presented as essential without a credible alternative.
Key takeaways
- “Advanced,” “biologic,” “holistic,” “regenerative,” and “AI-guided” are not levels of evidence.
- A valid recommendation names the diagnosis, proposed benefit, comparator, uncertainty, cost, and optional status.
- Surrogate outcomes should not be presented as proof of longer implant survival.
- Using several add-ons at once can obscure which component has evidence.
- Diagnosis, planning, skilled execution, a cleansable restoration, and maintenance remain foundational.
Evidence and decision snapshot
| Category | Possible value | Important limitation |
|---|---|---|
| Standard care | Directly connected to safety or execution | Still individualized |
| Selective adjunct | May improve comfort, handling, access, or a specific outcome | Benefit may be modest and not generalizable |
| Emerging option | May be reasonable with transparent consent | Uncertainty and alternatives must be disclosed |
| Unsupported package | May create convenience or confidence | Can add expense, risk, and distraction |
The difference between an adjunct and the foundation
Core implant care includes diagnosis, health and risk assessment, restoration-driven planning, infection management, atraumatic surgery, stability, healing, a maintainable restoration, and long-term care. An adjunct may support one step but cannot make the foundation optional.
A bundle containing PRF, ozone, lasers, vitamins, supplements, and monitoring has not necessarily been tested as a package.
Ask what problem and outcome the add-on addresses
A specific statement—such as improving graft handling or reducing early pain—is easier to evaluate than a promise to activate stem cells or guarantee regeneration. Ask what would happen without the add-on and whether core care would remain the same.
Laboratory antimicrobial activity, biomarkers, and short-term stability are surrogate outcomes. Patients ultimately care about pain, function, complications, retreatment, survival, and quality of life.
Judge evidence strength and value
Confidence depends on study design, consistency, directness, precision, bias, and relevance. A systematic review can still be limited by weak or heterogeneous studies. Honest language states both the estimated benefit and uncertainty.
Value includes expected absolute benefit, probability, severity of the problem, burden, risk, alternatives, and preferences—not price alone.
Price transparency, bundling, and warning signs
Patients should see whether an adjunct is included, optional, or billed separately and what happens if it is declined. Bundles should not obscure elective components.
Warning signs include guarantees, universal protocols, claims that conventional care is toxic, testimonials replacing evidence, undisclosed products or doses, pressure before diagnosis, and words such as “sterilizes,” “detoxifies,” or “100% integration.”
Frequently asked questions
Does “biologic implant protocol” have a standard definition?
No. It can describe very different materials, procedures, nutrition, and adjuncts. Ask for every component.
Is newer technology usually better?
Not necessarily. Benefit must be shown for the relevant outcome against competent conventional care.
Should I refuse every optional adjunct?
No. Optional does not mean useless; value depends on the defined problem, evidence, cost, and risk.
Questions to discuss with your implant team
- What specific problem does this adjunct address?
- What patient-centered outcome improved?
- Were studies performed with the same procedure or implant system?
- What fee, risk, inconvenience, and uncertainty are added?
- Can I decline it and still receive the same standard of core care?
What this means for patients: An add-on is worthwhile when it solves a defined problem with credible evidence and proportionate cost and risk. A long list of advanced services is not a substitute for excellent core implant care.
Selected references
- Guyatt GH, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008. doi:10.1136/bmj.39489.470347.AD.
- Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement. BMJ. 2010;340:c332. doi:10.1136/bmj.c332.
- American Dental Association. Evidence-based dental research resources.
- Herrera D, et al. Prevention and treatment of peri-implant diseases: the EFP S3 level clinical practice guideline. Journal of Clinical Periodontology. 2023. doi:10.1111/jcpe.13823.